Table of Contents
Journal of Radiotherapy
Volume 2014, Article ID 708317, 6 pages
http://dx.doi.org/10.1155/2014/708317
Research Article

Radiation Therapy Improves Survival Outcome in Pancreatic Adenocarcinoma: Comparison of a 15-Year Institutional Experience at the University of Nebraska Medical Center with SEER Data

1College of Medicine, University of Nebraska Medical Center, Omaha, NE 68198-7521, USA
2Department of Radiation Oncology, University of Nebraska Medical Center, Omaha, NE 68198-7521, USA

Received 11 September 2013; Accepted 29 October 2013; Published 27 January 2014

Academic Editor: Oliver Micke

Copyright © 2014 Michael J. Baine and Chi Lin. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Supplementary Material

Supplementary Tables 1 represents the Median overall survival (95% CI) with and without surgery using comparison data from both the University of Nebraska Medical Center (UNMC) as well as the National SEER database. Surgery is associated with the greatest increase in median overall survival described in this study at 13.0 months as compared to the 8.5 month survival advantage conferred by radiation therapy (RT).

Supplementary Table 2 represents the Median overall survival (95% CI) with and without chemotherapy (CT) using comparison data from the UNMC alone. SEER data was not included in this analysis as no CT data is provided by the SEER database. Overall, CT was associated with the smallest improvement in overall survival of the three treatment modalities analyzed at 7.9 months as compared to the 8.5 month survival advantage conferred by RT.

  1. Supplementary Table 1
  2. Supplementary Table 2